Equest
إيكويست جل فموي لعلاج طفيليات الخيول
Equest is an oral palatable gel for horses and ponies containing moxidectin (18.92 mg/g; 2.0% w/w). Indicated for the treatment and control of encysted small strongyle larvae (developing EL4, LL4, and mucosal L3 stages), large strongyles, ascarids, and stomach bots, with persistent suppression of strongyle egg shedding for 13 weeks.
Dosage Form
N/A
Product Type
Pharmaceutical
Manufacturer
Package
Multi-dose calibrated syringes of 11.8 g (treating up to 700 kg body weight)
Dosages
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Horse | 0.4 mg moxidectin/kg body weight (one syringe graduation mark per 25 kg) | Oral (PO) | Single oral dose every 13 weeks during grazing season |
Withdrawal Periods
| Species | Meat (days) | Milk (days) | Eggs (days) |
|---|---|---|---|
| Horse | 32 |
Indications
-
Treatment of encysted mucosal larvae of small strongyles (cyathostomins: EL4, LL4, and hypobiotic mucosal L3).
-
Treatment of adult and larval large strongyles (Strongylus vulgaris, Strongylus edentatus).
-
Treatment of Parascaris equorum, Oxyuris equi, and Gasterophilus intestinalis (stomach bots).
Contraindications
-
Do not use in foals under 4 months of age.
-
Do not use in cases of known hypersensitivity to moxidectin.
Precautions
-
Accurate dose setting is critical in small ponies and miniature horses.
Side Effects
-
Transient ataxia, depression, or flaccid lower lip at overdosage.
Images
Documents
-
Download
Equest Prescribing Information
Leaflet
Active Ingredients
Diseases
No diseases linked.
Related Products
No data available
Information has not been added yet.
Related Products By Active Ingredient
Companies
-
Zoetis
Manufacturer
Alternatives
No alternatives available.